Men's Decisions within Treatment and Care for Low Risk Prostate Cancer
Research type
Research Study
Full title
A Phenomenological Study to Determine what Influences Men's Decisions within Treatment and Care for Low Risk Prostate Cancer
IRAS ID
181240
Contact name
Paul M Arnold
Contact email
Sponsor organisation
University of Bradford
Duration of Study in the UK
0 years, 9 months, days
Research summary
Currently the clinical pathway for men with low risk prostate cancer is under review. Recent updates to NICE (National Institute for Health and Clinical Excellence) guidelines recommend men to be actively encouraged to make decisions regarding treatment and care for low risk prostate cancer. Decision making support has been identified as a key priority and healthcare professionals are required to establish the extent men wish to be actively involved within decision making for treatment and care. Therefore, it is essential to explore choices men make regarding treatment and care, as it is relatively unknown to healthcare professionals. One particular area of focus, where current literature is relatively limited, is men’s treatment and care decisions within low risk prostate cancer. This research aims to explore men’s experiences to determine what influences men's decisions within treatment and care for low risk prostate cancer. Data collection will comprise of telephone interviews, or where participant preferred, optional face-to-face interviews. An interview schedule will be followed to gather an understanding of men’s individual experiences. Questioning during the interview process will be based on general personal information and questions relating to treatment and care decisions for low risk prostate cancer. This research will take place within Hull and East Yorkshire Hospitals NHS Trust and comprise of a population of men from the Hull and East Yorkshire region. 10-12 participants is deemed proficient for in-depth interview. Men aged between 50-69 years old who have undergone treatment and care for low risk prostate cancer will be included. All participants will be attending a 9-15 month follow-up appointment in urology outpatients clinic after completing a period of treatment and care for low risk prostate cancer. The period between obtaining written consent, and telephone or optional face-to-face interview is estimated at 1 month.
REC name
Yorkshire & The Humber - Leeds East Research Ethics Committee
REC reference
16/YH/0128
Date of REC Opinion
12 Apr 2016
REC opinion
Favourable Opinion